Fresenius Medical Care AG & Co. KGaA (NYSE:FMS – Get Free Report) is one of 233 public companies in the “Healthcare Providers & Services” industry, but how does it weigh in compared to its rivals? We will compare Fresenius Medical Care AG & Co. KGaA to related businesses based on the strength of its risk, valuation, profitability, institutional ownership, dividends, earnings and analyst recommendations.
Institutional and Insider Ownership
8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. Comparatively, 56.7% of shares of all “Healthcare Providers & Services” companies are held by institutional investors. 15.0% of shares of all “Healthcare Providers & Services” companies are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Earnings and Valuation
This table compares Fresenius Medical Care AG & Co. KGaA and its rivals gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Fresenius Medical Care AG & Co. KGaA | $19.48 billion | $1.11 billion | 12.75 |
| Fresenius Medical Care AG & Co. KGaA Competitors | $21.44 billion | $301.67 million | -1.73 |
Fresenius Medical Care AG & Co. KGaA’s rivals have higher revenue, but lower earnings than Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.
Dividends
Fresenius Medical Care AG & Co. KGaA pays an annual dividend of $0.60 per share and has a dividend yield of 2.7%. Fresenius Medical Care AG & Co. KGaA pays out 34.7% of its earnings in the form of a dividend. As a group, “Healthcare Providers & Services” companies pay a dividend yield of 1.4% and pay out 24.7% of their earnings in the form of a dividend.
Volatility and Risk
Fresenius Medical Care AG & Co. KGaA has a beta of 0.78, meaning that its share price is 22% less volatile than the S&P 500. Comparatively, Fresenius Medical Care AG & Co. KGaA’s rivals have a beta of 0.98, meaning that their average share price is 2% less volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of current ratings and target prices for Fresenius Medical Care AG & Co. KGaA and its rivals, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Fresenius Medical Care AG & Co. KGaA | 5 | 7 | 0 | 0 | 1.58 |
| Fresenius Medical Care AG & Co. KGaA Competitors | 1877 | 7751 | 13384 | 833 | 2.55 |
Fresenius Medical Care AG & Co. KGaA presently has a consensus price target of $23.42, suggesting a potential upside of 6.16%. As a group, “Healthcare Providers & Services” companies have a potential upside of 13.48%. Given Fresenius Medical Care AG & Co. KGaA’s rivals stronger consensus rating and higher probable upside, analysts clearly believe Fresenius Medical Care AG & Co. KGaA has less favorable growth aspects than its rivals.
Profitability
This table compares Fresenius Medical Care AG & Co. KGaA and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Fresenius Medical Care AG & Co. KGaA | 4.23% | 9.08% | 4.04% |
| Fresenius Medical Care AG & Co. KGaA Competitors | -7.86% | -135.41% | -1.59% |
Summary
Fresenius Medical Care AG & Co. KGaA rivals beat Fresenius Medical Care AG & Co. KGaA on 9 of the 15 factors compared.
Fresenius Medical Care AG & Co. KGaA Company Profile
Fresenius Medical Care AG & Co. KGaA is a healthcare company focused on treating people with chronic kidney failure. It provides dialysis care through a global network of treatment centers and supports patients who receive care in clinics or at home. The company also develops and supplies products used in dialysis, including dialysis machines, dialyzers, and related medical equipment and materials. Its services include clinical care and support for healthcare providers involved in kidney treatment.
Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
